Work

Mcl-1 expression influcences CD8+ anti-tumor immunity.

Year: 2015
Type: article
Abstract: Meeting abstracts The recent clinical successes of immunotherapies such as anti-PD-1 and anti-CTLA-4 antibody blockade have re-invigorated the idea that the immune system has the potential to be a powerful tool to destroy tumors. However despite ample evidence that these therapies are able to
Institution: Cleveland Clinic
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2209824411
FWCI:
Cites:
Cited by: 1
Related to: 10